Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-09-01 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −2,146 35,281
2017-09-01 Schenkein David P Chief Executive Officer Option exercise +6,000 $0.30 $2K 6,000
2017-09-01 Schenkein David P Chief Executive Officer Sale −6,000 $62.20 $373K 0
2017-09-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 153,656
2017-08-23 Cantley Lewis Clayton Jr. Director Sale −500 $57.09 $29K 87,894
2017-08-23 Cantley Lewis Clayton Jr. Director Sale −500 $57.09 $29K 87,934
2017-08-23 Cantley Lewis Clayton Jr. Director Sale −500 $57.07 $29K 87,394
2017-08-23 Cantley Lewis Clayton Jr. Director Sale −500 $57.07 $29K 87,434
2017-08-22 Cantley Lewis Clayton Jr. Director Sale −500 $56.63 $28K 88,894
2017-08-22 Cantley Lewis Clayton Jr. Director Sale −500 $56.63 $28K 88,934
2017-08-22 Cantley Lewis Clayton Jr. Director Sale −500 $56.61 $28K 88,394
2017-08-22 Cantley Lewis Clayton Jr. Director Sale −500 $56.61 $28K 88,434
2017-08-02 Biller Scott Chief Scientific Officer Sale −21,000 $60.06 $1.3M 25,470
2017-08-02 Schenkein David P Chief Executive Officer Option exercise +24,000 $0.30 $7K 24,000
2017-08-02 Schenkein David P Chief Executive Officer Sale −24,000 $60.55 $1.5M 0
2017-08-02 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −24,000 159,656
2017-08-01 Biller Scott Chief Scientific Officer Option exercise +2,146 $9.05 $19K 8,410
2017-08-01 Biller Scott Chief Scientific Officer Sale −2,146 $55.05 $118K 6,264
2017-08-01 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −2,146 37,427
2017-08-01 Schenkein David P Chief Executive Officer Option exercise +3,000 $0.30 $908 3,000

Page 73 of 80 · 1,590 trades